7:51 am Teva Pharma receives CHMP positive opinion for DuoResp Spiromax for the treatment of patients diagnosed with asthma and COPD in Europe
View todays social media effects on TEVA
View the latest stocks trending across Twitter. Click to view dashboard
See who Teva is hiring next, click here to view
